Clinically relevant cancer chemotherapy dose scheduling via mixed-integer optimization

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Computers and Chemical Engineering

• Publication date

  2009-12-10

• Fields of study

  Medicine, Computer Science, Engineering

• Identifiers
  DOI 10.1016/j.compchemeng.2009.06.005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A physiologically-based pharmacokinetic (PBPK) and pharmacodynamic (PD) model of docetaxel (Doc) and neutropenia in humans

  2007cited by this paper
• Population Pharmacokinetic-Pharmacodynamic Model for Neutropenia with Patient Subgroup Identification: Comparison across Anticancer Drugs

  2006cited by this paper
• A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapy

  2006cited by this paper
• Adherence to medication.

  2005cited by this paper
• MODEL-BASED DESIGN OF CANCER CHEMOTHERAPY TREATMENT SCHEDULES

  2005cited by this paper
• Risks and benefits of phase 1 oncology trials, 1991 through 2002.

  2005cited by this paper
• Clinical applications of tumor volume measurements for predicting outcome in patients with squamous cell carcinoma of the upper aerodigestive tract.

  2004cited by this paper
• A Nonlinear Model Predictive Control Algorithm for Breast Cancer Treatment

  2004cited by this paper
• Predictive Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Kinetics in Xenograft Models after Administration of Anticancer Agents

  2004cited by this paper
• Maybe more is better.

  2003cited by this paper
• Measuring the side effects of taxane therapy in oncology

  2003cited by this paper
• Application of optimal control theory to analysis of cancer chemotherapy regimens

  2002cited by this paper
• Analysis of a mathematical model for the growth of tumors under the action of external inhibitors

  2002cited by this paper
• Stochastic models of progression of cancer and their use in controlling cancer-related mortality

  2002cited by this paper
• Cell Proliferation and Cell Death

  2002cited by this paper
• Optimal Bang-Bang Controls for a Two-Compartment Model in Cancer Chemotherapy

  2002cited by this paper
• Analysis of a class of optimal control problems arising in cancer chemotherapy

  2002cited by this paper
• Optimizing drug regimens in cancer chemotherapy: a simulation study using a PK-PD model

  2001cited by this paper
• Recovery of normal hemopoiesis in disseminated cancer therapy--a model.

  2001cited by this paper
• Cancer chemotherapy optimization under evolving drug resistance

  2001cited by this paper
• Surveillance for recurrent head and neck cancer using positron emission tomography.

  2000cited by this paper
• Tumor progression and metastasis.

  2000cited by this paper
• Molecular biology of breast cancer metastasis: The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer

  2000cited by this paper
• Topoisomerase I inhibitors: selectivity and cellular resistance.

  1999cited by this paper
• Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens.

  1998cited by this paper
• Propositional logic in control and monitoring problems

  1997cited by this paper
• Real-time estimation and control of particle size in semi-batch emulsion polymerization

  1997cited by this paper
• Batch chemical process quality control applied to curing of composite materials

  1997cited by this paper
• A mathematical model of cycle-specific chemotherapy

  1995cited by this paper
• Linear System Theory and Design

  1995cited by this paper
• Drug kinetics and drug resistance in optimal chemotherapy.

  1995cited by this paper
• Optimal Control of Drug Administration in Cancer Chemotherapy

  1993cited by this paper
• Optimal control drug scheduling of cancer chemotherapy

  1992cited by this paper
• An Optimal Control Algorithm For Multidrug Cancer Chemotherapy Design

  1990cited by this paper
• The Basic Science of Oncology

  1989cited by this paper
• Breast masses: mammographic evaluation.

  1989cited by this paper
• A Gompertzian model of human breast cancer growth.

  1988cited by this paper
• Robust process control

  1987cited by this paper
• Cancer chemotherapy: Optimal control using the Verhulst-Pearl equation

  1986cited by this paper
• Proceedings of the American Society of Clinical Oncology

  1982cited by this paper
• Advanced Engineering Mathematics

  1969cited by this paper

• Personalizing neoadjuvant chemotherapy regimens for triple-negative breast cancer using a biology-based digital twin

  2025cites this paper
• Algorithm 1053: SOLNP+: A Derivative-Free Solver for Constrained Nonlinear Optimization

  2024cites this paper
• Multimodality treatment planning using the Markov decision process: a comprehensive study of applications and challenges

  2024cites this paper
• Treatment of evolving cancers will require dynamic decision support

  2023cites this paper
• Systems Engineering Approach to Modeling and Analysis of Chronic Obstructive Pulmonary Disease Part II: Extension for Variable Metabolic Rates

  2023cites this paper
• SOLNP+: A Derivative-Free Solver for Constrained Nonlinear Optimization

  2022cites this paper
• Combination Chemotherapy Optimization with Discrete Dosing

  2021influential citation
• Combination Chemotherapy Optimization

  2020influential citation
• The combined effect of optimal control and swarm intelligence on optimization of cancer chemotherapy

  2020cites this paper
• Antitumour and anti-haematotoxic activity of Asparagus racemosus L total dissolved solids in co-administration with cyclophosphamide in mice

  2020cites this paper
• Toxicity-Centric Cancer Chemotherapy Treatment Design

  2020cites this paper
• Model-based Dose Individualization of Sunitinib in Gastrointestinal Stromal Tumors

  2020cites this paper
• Optimizing multi-modal cancer treatment under 3D spatio-temporal tumor growth.

  2019cites this paper
• Optimization of Drug Usage in Cancer Treatment using Combination of Chemotherapy and Immunotherapy

  2019cites this paper
• (μ,λ)-CCMA-ES for Constrained Optimization with an Application in Pharmacodynamics

  2019influential citation
• Design of diffusion‐controlled drug delivery devices for controlled release of Paclitaxel

  2019cites this paper
• Precision Medicine with Imprecise Therapy: Computational Modeling for Chemotherapy in Breast Cancer

  2018cites this paper
• A Robust Optimization Approach to Cancer Treatment under Toxicity Uncertainty.

  2018cites this paper
• In silicoAcute Myeloid Leukaemia

  2017cites this paper
• A multi-objective multi-drug model for cancer chemotherapy treatment planning: A cost-effective approach to designing clinical trials

  2016cites this paper
• Bio-inspired Computation Approach for Tumor Growth with Spatial Randomness Analysis of Kidney Cancer Xenograft Pathology Slides

  2016cites this paper
• Observer based feedback control of a biodynamical model of tumor growth with sampled measurements

  2016cites this paper
• A Personalized Framework for Dynamic Modeling of Disease Trajectories in Chronic Lymphocytic Leukemia

  2016cites this paper
• Adaptive modelling of tumour volume dynamics under radiotherapy

  2016cites this paper
• Théorie des ensembles pour le contrôle robuste des systèmes non linéaires : Application à la chimiothérapie et les thérapies anti-angiogéniques

  2016cites this paper
• A mathematical model of cell cycle heterogeneity for personalizing leukemia chemotherapy

  2015cites this paper
• Dynamic Modeling of Drug Transport in Solid Tumors and Optimal Chemotherapy Regimen

  2015cites this paper
• Data-driven modeling of pharmacological systems using endpoint information fusion

  2015cites this paper
• Genomic based personalized chemotherapy analysis to support decision systems for breast cancer

  2015cites this paper
• FINITE DURATION TREATMENT OF CANCER BY USING VACCINE THERAPY AND OPTIMAL CHEMOTHERAPY: STATE-DEPENDENT RICCATI EQUATION CONTROL AND EXTENDED KALMAN FILTER

  2015cites this paper
• Mathematical modelling of tumour volume dynamics in response to stereotactic ablative radiotherapy for non-small cell lung cancer

  2015cites this paper
• Combine operations research with molecular biology to stretch pharmacogenomics and personalized medicine - A case study on HIV/AIDS

  2015cites this paper
• Suboptimal mixed vaccine and chemotherapy in finite duration cancer treatment: state-dependent Riccati equation control

  2015cites this paper
• ON THE CONTROL OF TUMOR GROWTH VIA TYPE-1 AND INTERVAL TYPE-2 FUZZY LOGIC

  2015cites this paper
• Neutrophil dynamics during concurrent chemotherapy and G-CSF administration: Mathematical modelling guides dose optimisation to minimise neutropenia.

  2015cites this paper
• A gene expression-based mathematical modeling approach for breast cancer tumor growth and shrinkage

  2015influential citation
• Review of Optimization Methods for Cancer Chemotherapy Treatment Planning

  2015cites this paper
• Optimization of drug regimen in chemotherapy based on semi-mechanistic model for myelosuppression

  2015cites this paper
• A systematic framework for the design, simulation and optimization of personalized healthcare: Making and healing blood

  2015cites this paper
• Model-Based Tumor Growth Dynamics and Therapy Response in a Mouse Model of De Novo Carcinogenesis

  2015cites this paper
• Optimal Finite Cancer Treatment Duration by Using Mixed Vaccine Therapy and Chemotherapy: State Dependent Riccati Equation Control

  2014cites this paper
• Ubiquity: a framework for physiological/mechanism-based pharmacokinetic/pharmacodynamic model development and deployment

  2014cites this paper
• Mathematical models for absorption and efficacy of ovarian cancer treatments

  2014cites this paper
• Multi-objective particle swarm optimisation : methods and applications

  2014cites this paper
• PROPOSING OPTIMAL CHEMOTHERAPY PROTOCOL FOR CANCER TREATMENT WITH METASTASIS BY USING SDRE BASED OPTIMAL CONTROL TECHNIQUE

  2014cites this paper
• Evaluation of anti-cancer therapy using in silico analysis of treatments for HER2+ breast cancer

  2014influential citation
• A model-based clinically-relevant chemotherapy scheduling algorithm for anticancer agents

  2014cites this paper
• A survey of optimization models on cancer chemotherapy treatment planning

  2014cites this paper
• Suboptimal mixed vaccine and chemotherapy in finite duration cancer treatment: state-dependent Riccati equation control

  2014cites this paper
• Mathematical Modeling of Tumor Growth, Drug-Resistance, Toxicity, and Optimal Therapy Design

  2014cites this paper
• ENVISION - a novel computational platform for oncology study

  2013cites this paper
• Modelling and optimisation based drug delivery systems for the treatment of Acute Myeloid Leukemia (AML)

  2013cites this paper
• Multi-objective multi-drug scheduling schemes for cell cycle specific cancer treatment

  2013cites this paper
• Design of optimal patient-specific chemotherapy protocols for the treatment of acute myeloid leukemia (AML)

  2013cites this paper
• Towards tumor growth control subject to reduced toxicity

  2012cites this paper
• erapies ambulatoires avec la prise en compte des protocoles de soins et des incertitudes.

  2012cites this paper
• Model-based control of tumor progression

  2012cites this paper
• Multi-objective optimisation of cancer chemotherapy using smart PSO with decomposition

  2011cites this paper
• Simultaneous mixed-integer dynamic optimization for environmentally benign electroplating

  2011cites this paper
• A survey of optimization models on cancer chemotherapy treatment planning

  2011influential citation
• APLIKASI KENDALI OPTIMUM DALAM PENENTUAN INTERVAL WAKTU DAN DOSIS OPTIMAL PADA KEMOTERAPI KANKER

  2011cites this paper
• Tumor irrigation model for virotherapy cancer treatment

  2011cites this paper
• Türkçe ve İngilizce bilimsel makale özetlerinde bilgiyi kurgulama ve yazar kimliğini kodlama biçimleri

  2011cites this paper
• Systems engineering medicine: engineering the inflammation response to infectious and traumatic challenges

  2010cites this paper
• Accelerated optimisation of chemotherapy dose schedules using fitness inheritance

  2010cites this paper
• The role of Computer Aided Process Engineering in physiology and clinical medicine

  2010cites this paper
• Optimasi dalam Penentuan Dosis Optimal pada Kemoterapi Tumor

  2010cites this paper
• Modeling Tumor Growth for Kidney Cancer Based on Nuclei Clusters of Pathology Slides

  year unknowncites this paper
• Computers and Chemical Engineering Multi-objective Multi-drug Scheduling Schemes for Cell Cycle Specific Cancer Treatment

  year unknowncites this paper